FDA drug approvals
Every approval of a new drug, generic or biologic by the US Food and Drug Administration, newest first, under the company that holds the application today, from Drugs@FDA. 25,670 approvals on file, 13,159 held by companies on value.today.
Approvals, 2026
724
all applicants
50
New uses approved, 2026
196
efficacy supplements
Approvals, 2025
824
50 new molecules
FDA approvals in 2025
824 approvals, newest first.
| Approved | Drug | Held by | Kind |
|---|---|---|---|
| 2025-12-31 | Glatiramer AcetateGlatiramer Acetate · Injectable · Subcutaneous · ANDA214741 | 🇹🇼 ScinoPharm Taiwan, Ltd. | Generic drug (ANDA) |
| 2025-12-31 | Selenious AcidSelenious Acid · Solution · Intravenous · ANDA218536 | STIRA | Generic drug (ANDA) |
| 2025-12-31 | Ketamine HydrochlorideKetamine Hydrochloride · Solution · Intramuscular, Intravenous · ANDA220380 | 🇺🇸 Amneal Pharmaceuticals, Inc. | Generic drug (ANDA) |
| 2025-12-30 | Calcium Gluconate In Sodium ChlorideCalcium Gluconate · Solution · Intravenous · ANDA219619 | SAGENT | Generic drug (ANDA) |
| 2025-12-30 | Nereusnew moleculeTradipitant · Capsule · Oral · NDA220152 | 🇺🇸 Vanda Pharmaceuticals Inc. | New drug (NDA) |
| 2025-12-29 | Sitagliptin PhosphateSitagliptin Phosphate · Tablet · Oral · ANDA202327 | 🇮🇱 Teva Pharmaceutical Industries Limited | Generic drug (ANDA) |
| 2025-12-29 | Pseudoephedrine HydrochloridePseudoephedrine Hydrochloride · Tablet, Extended Release · Oral · ANDA218854 | 🇮🇳 Aurobindo Pharma Limited | Generic drug (ANDA) |
| 2025-12-29 | Epoprostenol SodiumEpoprostenol Sodium · Injectable · Injection · ANDA219237 | 🇮🇳 Gland Pharma Limited | Generic drug (ANDA) |
| 2025-12-29 | Loperamide HydrochlorideLoperamide Hydrochloride · Capsule · Oral · ANDA220372 | 🇮🇳 Aurobindo Pharma Limited | Generic drug (ANDA) |
| 2025-12-23 | Ephedrine SulfateEphedrine Sulfate · Solution · Intravenous · ANDA215593 | CIVICA | Generic drug (ANDA) |
| 2025-12-23 | Methylene BlueMethylene Blue · Solution · Intravenous · ANDA219550 | CHENGDU SHUODE | Generic drug (ANDA) |
| 2025-12-23 | GlycopyrrolateGlycopyrrolate · Solution · Oral · ANDA220062 | BIONPHARMA | Generic drug (ANDA) |
| 2025-12-23 | Yartemleanew moleculepriority reviewNarsoplimab-Wuug · Injection · BLA761152 | 🇺🇸 Omeros Corporation | Biologic (BLA) |
| 2025-12-22 | Potassium ChloridePotassium Chloride · Solution · Oral · ANDA215716 | QUAGEN | Generic drug (ANDA) |
| 2025-12-22 | Mucinex 12Hr Cold & Fever Multi-SymptomDextromethorphan Hydrobromide, Guaifenesin, Naproxen Sodium · Tablet, Extended Release · Oral · NDA217338 | RECKITT BENCKISER | New drug (NDA) |
| 2025-12-22 | WegovySemaglutide · Tablet · Oral · NDA218316 | NOVO | New drug (NDA) |
| 2025-12-19 | DecitabineDecitabine · Injectable · Intravenous · ANDA217814 | SOMERSET THERAPS LLC | Generic drug (ANDA) |
| 2025-12-19 | BoncresaDenosumab-Mobz · Injectable · Subcutaneous · BLA761456 | 🇺🇸 Amneal Pharmaceuticals, Inc. | Biologic (BLA) |
| 2025-12-19 | OziltusDenosumab-Mobz · Injectable · Subcutaneous · BLA761457 | 🇺🇸 Amneal Pharmaceuticals, Inc. | Biologic (BLA) |
| 2025-12-19 | Myqorzonew moleculeAficamten · Tablet · Oral · NDA219083 | 🇺🇸 Cytokinetics, Incorporated | New drug (NDA) |
| 2025-12-19 | Jascaydpriority reviewNerandomilast · Tablet · Oral · NDA220449 | 🇩🇪 Boehringer Ingelheim | New drug (NDA) |
| 2025-12-18 | Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate · Tablet · Oral · ANDA206157 | MICRO LABS | Generic drug (ANDA) |
| 2025-12-18 | HaloperidolHaloperidol · Tablet · Oral · ANDA218162 | CREEKWOOD PHARMS | Generic drug (ANDA) |
| 2025-12-18 | NitroglycerinNitroglycerin · Ointment · Intra-Anal · ANDA218756 | AMVIKA | Generic drug (ANDA) |
| 2025-12-18 | Buprenorphine HydrochlorideBuprenorphine Hydrochloride · Tablet · Sublingual · ANDA219401 | ASCENT PHARMS INC | Generic drug (ANDA) |
| 2025-12-18 | NufymcoRanibizumab-Leyk · Injection · BLA761473 | 🇩🇪 Formycon AG | Biologic (BLA) |
| 2025-12-17 | TravoprostTravoprost · Solution/Drops · Ophthalmic · ANDA214687 | ALEMBIC | Generic drug (ANDA) |
| 2025-12-17 | BortezomibBortezomib · Injectable · Intravenous, Subcutaneous · ANDA216528 | SHUANGCHENG | Generic drug (ANDA) |
| 2025-12-17 | LatanoprostLatanoprost · Solution/Drops · Ophthalmic · ANDA220360 | 🇮🇳 Mankind Pharma Limited | Generic drug (ANDA) |
| 2025-12-17 | Rybrevant Faspropriority reviewAmivantamab And Hyaluronidase-Lpuj · Injection · BLA761433 | 🇺🇸 Johnson & Johnson | Biologic (BLA) |
| 2025-12-16 | Beclomethasone DipropionateBeclomethasone Dipropionate · Aerosol, Metered · Inhalation · ANDA213811 | AMNEAL IRELAND LTD | Generic drug (ANDA) |
| 2025-12-16 | Cariprazine HydrochlorideCariprazine Hydrochloride · Capsule · Oral · ANDA213982 | 🇮🇳 Aurobindo Pharma Limited | Generic drug (ANDA) |
| 2025-12-16 | Hydroxyzine HydrochlorideHydroxyzine Hydrochloride · Syrup · Oral · ANDA219648 | NOVITIUM PHARMA | Generic drug (ANDA) |
| 2025-12-16 | Exdensurnew moleculeDepemokimab-Ulaa · Injection · BLA761458 | 🇬🇧 GSK plc | Biologic (BLA) |
| 2025-12-16 | VybriqueSildenafil Citrate · Film · Oral · NDA210858 | IBSA | New drug (NDA) |
| 2025-12-15 | Nilotinib, Nilotinib HydrochlorideNilotinib, Nilotinib Hydrochloride · Capsule, Capsule · Oral · ANDA218532 | 🇮🇳 Torrent Pharmaceuticals Limited | Generic drug (ANDA) |
| 2025-12-15 | Buprenorphine Hydrochloride And Naloxone HydrochlorideBuprenorphine Hydrochloride, Naloxone Hydrochloride · Tablet · Sublingual · ANDA219727 | ASCENT PHARMS INC | Generic drug (ANDA) |
| 2025-12-12 | TeriparatideTeriparatide · Solution · Subcutaneous · ANDA213641 | 🇺🇸 Amphastar Pharmaceuticals, Inc. | Generic drug (ANDA) |
| 2025-12-12 | Octreotide AcetateOctreotide Acetate · Injectable · Injection · ANDA216589 | MYLAN LABS LTD | Generic drug (ANDA) |
| 2025-12-12 | DeflazacortDeflazacort · Tablet · Oral · ANDA217173 | 🇺🇸 Amneal Pharmaceuticals, Inc. | Generic drug (ANDA) |
| 2025-12-12 | Lerocholnew moleculeLerodalcibep-Liga · Injectable · Injection · BLA761427 | LIB THERAPEUTICS, INC. | Biologic (BLA) |
| 2025-12-12 | Cardamystnew moleculeEtripamil · Spray · Nasal · NDA218571 | MILESTONE PHARMS USA | New drug (NDA) |
| 2025-12-12 | Nuzolvencenew moleculepriority reviewZoliflodacin · For Suspension · Oral · NDA219491 | ENTASIS THERAP | New drug (NDA) |
| 2025-12-11 | Lopinavir And RitonavirLopinavir, Ritonavir · Tablet · Oral · ANDA214696 | MICRO LABS | Generic drug (ANDA) |
| 2025-12-11 | Norepinephrine BitartrateNorepinephrine Bitartrate · Injectable · Injection · ANDA218595 | MSN | Generic drug (ANDA) |
| 2025-12-11 | Acetaminophen And IbuprofenAcetaminophen, Ibuprofen · Tablet · Oral · ANDA220126 | LNK INTL INC | Generic drug (ANDA) |
| 2025-12-11 | DeferiproneDeferiprone · Tablet · Oral · ANDA220132 | PHARMAZONE | Generic drug (ANDA) |
| 2025-12-11 | Orladeyopriority reviewBerotralstat Dihydrochloride · Pellets · Oral · NDA219776 | 🇺🇸 BioCryst Pharmaceuticals, Inc. | New drug (NDA) |
| 2025-12-11 | Daybue StixTrofinetide · For Solution · Oral, Solution · Oral · NDA219884 | 🇺🇸 Acadia Pharmaceuticals Inc. | New drug (NDA) |
| 2025-12-10 | Isoproterenol HydrochlorideIsoproterenol Hydrochloride · Injectable · Injection · ANDA213305 | DEVA HOLDING AS | Generic drug (ANDA) |
Most approvals in 2025
Companies on value.today.
Source: US Food and Drug Administration, Drugs@FDA (openFDA) · as of Nov 13, 2026. Approvals follow the application to its current holder, so an acquired company's approvals appear under the buyer. Vaccines and blood products are approved by another FDA centre and are not listed. How it is counted